Food and Drug Regulations (C.R.C., c. 870)

Marginal note:Return of licence

G.02.029 The licensed dealer must return the original of the licence to the Minister within 15 days after the effective date of the revocation.

Import Permits

Marginal note:Application

• G.02.030 (1) A licensed dealer must submit to the Minister, before each importation of a controlled drug, an application for an import permit that contains the following information:

  • (a) their name, municipal address and dealer’s licence number;

  • (b) with respect to the controlled drug to be imported,

    • (i) its name, as specified in the dealer’s licence,

    • (ii) if it is a salt, the name of the salt,

    • (iii) its quantity, and

    • (iv) in the case of a raw material, its purity and its anhydrous content;

  • (c) if the controlled drug is contained in a product to be imported,

    • (i) the brand name of the product,

    • (ii) the drug identification number that has been assigned to the product under section C.01.014.2, if any, and

    • (iii) the strength per unit of the controlled drug in the product, the number of units per package and the number of packages;

  • (d) the name and municipal address, in the country of export, of the exporter from whom the controlled drug is being obtained;

  • (e) the name of the customs office where the importation is anticipated; and

  • (f) each proposed mode of transportation and any proposed country of transit or transhipment.

• Marginal note:Signature and attestation

  (2) The application must

  • (a) be signed and dated by the qualified person in charge or an alternate qualified person in charge; and

  • (b) include an attestation by that person that all of the information submitted in support of the application is correct and complete to the best of their knowledge.

• Marginal note:Additional information and documents

  (3) The licensed dealer must, not later than the date specified in the Minister’s written request to that effect, provide the Minister with any information or document that the Minister determines is necessary to complete the review of the application.

Marginal note:Issuance

G.02.031 Subject to section G.02.034, on completion of the review of the import permit application, the Minister must issue to the licensed dealer an import permit that contains

• (a) the permit number;

• (b) the information set out in subsection G.02.030(1);

• (c) the effective date of the permit;

• (d) the expiry date of the permit, being the earlier of

  • (i) a date specified by the Minister that is not more than 180 days after its effective date, and

  • (ii) the expiry date of the dealer’s licence; and

• (e) any terms and conditions that the Minister has reasonable grounds to believe are necessary to

  • (i) ensure that an international obligation is respected, or

  • (ii) reduce a risk to public health or safety, including the risk of a controlled drug being diverted to an illicit market or use.

Marginal note:Validity

G.02.032 An import permit is valid until the earliest of

• (a) the expiry date set out in the permit,

• (b) the date of the suspension or revocation of the permit under section G.02.037 or G.02.038,

• (c) the date of the suspension or revocation of the dealer’s licence under section G.02.027 or G.02.028, and

• (d) the date of the suspension or revocation of the export permit that applies to the controlled drug to be imported and that is issued by the competent authority in the country of export.

Marginal note:Return of permit

G.02.033 If an import permit expires, the licensed dealer must return the original of the permit to the Minister within 15 days after its expiry.

Marginal note:Refusal

• G.02.034 (1) The Minister must refuse to issue an import permit if

  • (a) the licensed dealer is not authorized by their dealer’s licence to import the relevant controlled drug or their licence will expire before the date of importation;

  • (b) the Minister has reasonable grounds to believe that the importation would contravene an international obligation;

  • (c) the licensed dealer does not have in place at the site the security measures set out in the Security Directive in respect of the importation;

  • (d) the licensed dealer has not complied with the requirements of subsection G.02.030(3) or the information or documents that they have provided are not sufficient to complete the review of the permit application;

  • (e) the Minister has reasonable grounds to believe that the licensed dealer has submitted false or misleading information or false or falsified documents in or in support of the permit application;

  • (f) the licensed dealer has been notified that their application to renew or amend their licence will be refused;

  • (g) the Minister has reasonable grounds to believe that the importation would contravene the laws of the country of export or any country of transit or transhipment; or

  • (h) the Minister has reasonable grounds to believe that the issuance of the permit would likely create a risk to public health or safety, including the risk of a controlled drug being diverted to an illicit market or use.

• Marginal note:Notice

  (2) Before refusing to issue the import permit, the Minister must send the licensed dealer a notice that sets out the Minister’s reasons and gives the dealer an opportunity to be heard.

Marginal note:Providing copy of permit

G.02.035 The holder of an import permit must provide a copy of the permit to the customs office at the time of importation.

Marginal note:Declaration

G.02.036 The holder of an import permit must provide the Minister, within 15 days after the day of release of the controlled drug specified in the permit in accordance with the Customs Act, with a declaration that contains the following information:

• (a) their name and the numbers of their dealer’s licence and the import permit that applies to the controlled drug;

• (b) with respect to the controlled drug,

  • (i) its name, as set out in the dealer’s licence,

  • (ii) if it is a salt, the name of the salt, and

  • (iii) its quantity;

• (c) if the controlled drug is contained in a product that they have imported,

  • (i) the brand name of the product,

  • (ii) the drug identification number that has been assigned to the product under section C.01.014.2, if any, and

  • (iii) the strength per unit of the controlled drug in the product, the number of units per package and the number of packages; and

• (d) the name of the customs office from which the controlled drug was released and the date of the release.